Senior insider sale
General Counsel at ROCKET PHARMACEUTICALS, INC. — senior position signals high conviction
$45.5K
13.90K shares
What this filing means
WILSON MARTIN plans to sell 13.90K shares of ROCKET PHARMACEUTICALS, INC. valued at approximately $45.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/13/2026ACC: 0001959173-26-001000
Officer· General Counsel
Since Dec 2021
13.90K
Shares to sell
$45.5K
Approx. market value
12.25K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/11/2026
12.25KTotal acquired12.25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/11/2026 | Restricted Stock Vesting Compensation | 12.25K | — |
| Total | 12.25K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.65K
Market value
$4.9K
11/18/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
12.25K
Market value
$40.6K
2/13/2026
Total
Units
13.90K
Value
$45.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/18/2025 | 1.65K | $4.9K | — | Completed |
| Planned — Approximate Date | ||||
2/13/2026 | 12.25K | $40.6K | NASDAQ | Planned |
| Total | 13.90K | $45.5K | ||